Bojiao Yin
About Bojiao Yin
Bojiao Yin serves as the Director of Vector Process Development at ElevateBio, where he has worked since 2022. He has a strong background in metabolic engineering and extensive experience in vector process development, particularly in optimizing lentiviral vectors.
Work at ElevateBio
Bojiao Yin has served as the Director at ElevateBio since 2022, contributing to the company's advancements in vector process development. In this role, he oversees the development of the Lentiviral Vector Platform, focusing on optimizing lentiviral vectors for both functional and safety features. His leadership includes managing a team that provides core services for virus production at the research level. Prior to his current position, he held the role of Associate Director of Vector Process Development and Manufacturing from 2020 to 2022 and served as Sr. Scientist in the same department from 2019 to 2020.
Education and Expertise
Bojiao Yin earned his Doctor of Philosophy (Ph.D.) from Sun Yat-Sen University, where he studied from 2004 to 2009. He furthered his education at The Johns Hopkins University, achieving a postdoctoral fellowship in Protein Biochemistry and Chemical Engineering from 2011 to 2015. His expertise encompasses metabolic engineering, media and supplement development, and post-translational modification. He is experienced in tech transfer processes and has a strong background in host cell line adaptation and genetic modification.
Background
Bojiao Yin's professional journey includes significant roles in various organizations. He worked as a Graduate Research Assistant at the Chinese Academy of Sciences from 2005 to 2009. Following this, he joined Amgen as a Scientist from 2015 to 2019, where he contributed to projects in Cambridge, Massachusetts. He transitioned to ElevateBio, where he has held multiple positions, enhancing his expertise in vector process development and manufacturing.
Achievements
Throughout his career, Bojiao Yin has demonstrated a commitment to fostering cohesive team cultures and effective project management. He has played a key role in the development of ElevateBio's Lentiviral Vector Platform and has contributed to optimizing lentiviral vectors. His hands-on experience in vector process development has been instrumental in advancing the company's capabilities in viral vector production.